KIF2C and central nervous system cancer: In addition, our results showed that KIF2C was higher in IDH1 wild-type samples than IDH1 mutant glioma samples (Figure 6(d)), and KIF2C was higher in 1p/19q noncodel samples than 1p/19q code glioma samples (Figure 6(e)).